December 4, 2020
UC researchers are seeking participants in a study for an opioid addiction treatment that could weaken withdrawal symptoms and increase the likelihood of recovery for pregnant women.
September 16, 2022
The Cincy BEARCAT study aims to learn more about the causes of cardiac arrest. The just-launched study will create a biorepository of blood samples that can be used in this project as well as future research. The hypothesis is that there is a lot of diversity in cardiac arrest patients as far as the cause of the cardiac arrest.
October 27, 2020
A Cincinnati surgeon has been named among the nation’s top “40 under 40” in cancer care.
October 2, 2020
A research center devoted to the science of addiction and determined to make a national impact has launched at the University of Cincinnati College of Medicine.
May 4, 2021
Bethany Yeiser is working to educate others about schizophrenia through the CURESZ Foundation, which she founded with UC's Henry Nasrallah, the doctor who got her on the path to recovery.
February 23, 2021
E. Steve Woodle, MD, professor of surgery at the University of Cincinnati, authored a study that shows that 15 years after transplantation no difference in kidney transplant survival or patient survival rates were found between kidney transplant patients who received long-term corticosteroids versus those who had corticosteroid eliminated early.
July 9, 2020
Immediately following the announcement of COVID-19 prevention measures in March, the Greater Cincinnati Tristate region saw a nearly 40% decline in patients coming to the hospital in time for emergency stroke care, according to researchers from the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital Medical Center. The researchers are calling for urgent public education to mitigate a potential crisis of stroke patients avoiding needed emergency care due to concerns about COVID-19
October 12, 2020
In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction. The grant was awarded to Caroline Freiermuth, MD, associate professor in the Department of Emergency Medicine at the UC College of Medicine, the principal investigator for the study. The initial year will be supported with $1.63 million from the attorney general’s office, secured through money collected from pharmaceutical companies involved in opioid lawsuits. Pharmacogenomics, a relatively new field, is the study of how genes affect a person's response to drugs.
October 1, 2020
The UC College of Medicine has established the Center for Addiction Research to expand the university’s scope as a national leader in addiction science.
February 15, 2022
The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a nationwide double-blind study expected to enroll nearly 15,000 participants from across the United States through its website.